BioSpace News Archive

Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation

Median Technologies announces the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients.

July 21, 2023
·
2 min read
Deals

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering - July 21, 2023

Turnstone Biologics Corp. announced the pricing of its upsized initial public offering of 6,666,667 shares of common stock at a price to the public of $12.00 per share.

July 21, 2023
·
3 min read
Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of breakthrough therapies

Molecure completes successful Secondary Public Offering (SPO) of approximately PLN50 million (USD12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of break through therapies

July 21, 2023
·
6 min read
Drug Development

Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine Results From European Phase III Study (PYTHON Trial)

Curium announced the publication of the results of its European, multicenter, prospective cross-over clinical trial which compared [18F] piflufolastat versus [18F]fluoromethylcholine PET/CT in patients with first biochemical recurrence of prostate cancer.

July 21, 2023
·
4 min read